Re‐calibration and performance of a proteomic prognostic test for 5‐year dementia risk

Background Proteomics‐driven health and wellness tests can provide personalized insight into individual risk for disease that is sensitive to change across time. The SomaSignalTM Mid‐Life Dementia Risk Test is a blood‐based, protein‐only prognostic model developed using SomaScan® Assay v4.0 (measuri...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2023-12, Vol.19 (S14), p.n/a
Hauptverfasser:	Paterson, Clare, Loupy, Kelsey, Biegel, Hannah, Hagar, Yolanda, Ostroff, Rachel, Sampson, Laura, Bogren, Lori K, Williams, Stephen A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!